Beautiful Virgin Islands

Wednesday, Jul 16, 2025

Scientists take ‘important step’ in stem cell therapy to treat Parkinson’s

Scientists take ‘important step’ in stem cell therapy to treat Parkinson’s

Chinese Academy of Sciences team discovered a new technique they say improved efficacy and safety in study on mice.

Chinese researchers have discovered a new technique they say improved the efficacy and safety of stem cell therapy in mice models of Parkinson’s disease.

The team from the Chinese Academy of Sciences (CAS) said their study findings paved the way for potentially developing a stem cell therapy to treat the disease.

The researchers identified two cell surface markers of dopamine neurons, which are damaged or destroyed in the midbrain of someone with Parkinson’s disease.

They then injected cells with these markers into the brains of mice, which they found could significantly improve the dopamine neurons in the midbrain – a key step in the treatment of the disease.

The finding “represents a revolutionary step on the road towards more effective and safer stem cell therapies”, according to the study, published in the Journal of Clinical Investigation on Tuesday.




Neurological disorders are the leading source of disability globally, and Parkinson’s disease is the second most common neurodegenerative disorder after Alzheimer’s. There is no cure for Parkinson’s disease, but the symptoms can be managed with medications and other therapies.

Worldwide, some 6.1 million people had Parkinson’s disease in 2016, according to the Lancet’s Global Burden of Disease Study in 2018. That number is expected to double to more than 12 million by 2040.

In China, it is estimated that the number of Parkinson’s disease patients could rise to about 5 million by 2030, accounting for half of the world’s cases.

Parkinson’s disease is a degenerative disorder affected by the impairment or death of cells in deep parts of the brain called the substantia nigra, which produces the neurotransmitter dopamine and controls body movement.

When 60 to 80 per cent of dopamine is lost, Parkinson’s symptoms such as tremor and balance problems occur.

Stem cell therapy is considered to be a promising treatment strategy because the disease is caused by the loss of one type of cell from a certain spot in the brain.

“Parkinson’s disease is the most suitable one [for stem cell therapy] because it is very clear which cells are lost and where should they be transplanted,” said Chen Yuejun, corresponding author of the study and a researcher with the CAS.

However, previous studies have generated both target and off-target neuronal cells during transplantation, resulting in low efficacy and uncertainty around safety.

“Our study wanted to answer two questions – why the previous studies generated more than a dozen off-target cells, and how we could enrich [certain] cells,” said Chen, who heads the Laboratory of Neural Differentiation and Regeneration at the CAS.

Stem cell therapy is seen as a promising strategy to treat Parkinson’s disease.


Chen and the team did a single-cell sequencing of dopaminergic neurons and found that the off-target cells were generated in areas near the midbrain.

They also found two markers that could facilitate highly enriched dopaminergic neurons after transplantation.

The percentage of neurons could be as high as 80 per cent in the transplant area, according to the paper. That compares to about 10 per cent in two recent preclinical studies.

“The study established a method for obtaining highly purified donor cells that can be transplanted with stable and predictable cell therapy results,” the authors said in a statement on the CAS website.

“It is an important step towards more effective and safer cell therapy for Parkinson’s disease.”

Newsletter

Related Articles

Beautiful Virgin Islands
0:00
0:00
Close
Dimon Warns on Fed Independence as Trump Administration Eyes Powell’s Succession
Church of England Removes 1991 Sexuality Guidelines from Clergy Selection
Superman Franchise Achieves Success with Latest Release
Hungary's Viktor Orban Rejects Agreements on Illegal Migration
Jeff Bezos Considers Purchasing Condé Nast as a Wedding Gift
Ghislaine Maxwell Says She’s Ready to Testify Before Congress on Epstein’s Criminal Empire
Bal des Pompiers: A Celebration of Community and Firefighter Culture in France
FBI Chief Kash Patel Denies Resignation Speculations Amid Epstein List Controversy
Air India Pilot’s Mental Health Records Under Scrutiny
Google Secures Windsurf AI Coding Team in $2.4 Billion Licence Deal
Jamie Dimon Warns Europe Is Losing Global Competitiveness and Flags Market Complacency
South African Police Minister Suspended Amid Organised Crime Allegations
Nvidia CEO Claims Chinese Military Reluctance to Use US AI Technology
Hong Kong Advances Digital Asset Strategy to Address Economic Challenges
Australia Rules Out Pre‑commitment of Troops, Reinforces Defence Posture Amid US‑China Tensions
Martha Wells Says Humanity Still Far from True Artificial Intelligence
Nvidia Becomes World’s First Four‑Trillion‑Dollar Company Amid AI Boom
U.S. Resumes Deportations to Third Countries After Supreme Court Ruling
Excavation Begins at Site of Mass Grave for Children at Former Irish Institution
Iranian President Reportedly Injured During Israeli Strike on Secret Facility
EU Delays Retaliatory Tariffs Amid New U.S. Threats on Imports
Trump Defends Attorney General Pam Bondi Amid Epstein Memo Backlash
Renault Shares Drop as CEO Luca de Meo Announces Departure Amid Reports of Move to Kering
Senior Aides for King Charles and Prince Harry Hold Secret Peace Summit
Anti‑Semitism ‘Normalised’ in Middle‑Class Britain, Says Commission Co‑Chair
King Charles Meets David Beckham at Chelsea Flower Show
If the Department is Really About Justice: Ghislaine Maxwell Should Be Freed Now
NYC Candidate Zohran Mamdani’s ‘Antifada’ Remarks Spark National Debate on Political Language and Economic Policy
President Trump Visits Flood-Ravaged Texas, Praises Community Strength and First Responders
From Mystery to Meltdown, Crisis Within the Trump Administration: Epstein Files Ignite A Deepening Rift at the Highest Levels of Government Reveals Chaos, Leaks, and Growing MAGA Backlash
Trump Slams Putin Over War Death Toll, Teases Major Russia Announcement
Reparations argument crushed
Rainmaker CEO Says Cloud Seeding Paused Before Deadly Texas Floods
A 92-year-old woman, who felt she doesn't belong in a nursing home, escaped the death-camp by climbing a gate nearly 8 ft tall
French Journalist Acquitted in Controversial Case Involving Brigitte Macron
Elon Musk’s xAI Targets $200 Billion Valuation in New Fundraising Round
Kraft Heinz Considers Splitting Off Grocery Division Amid Strategic Review
Trump Proposes Supplying Arms to Ukraine Through NATO Allies
EU Proposes New Tax on Large Companies to Boost Budget
Trump Imposes 35% Tariffs on Canadian Imports Amid Trade Tensions
Junior Doctors in the UK Prepare for Five-Day Strike Over Pay Disputes
US Opens First Rare Earth Mine in Over 70 Years in Wyoming
Kurdistan Workers Party Takes Symbolic Step Towards Peace in Northern Iraq
Bitcoin Reaches New Milestone of $116,000
Biden’s Doctor Pleads the Fifth to Avoid Self-Incrimination on President’s Medical Fitness
Grok Chatbot Faces International Backlash for Antisemitic Content
Severe Heatwave Claims 2,300 Lives Across Europe
NVIDIA Achieves Historic Milestone as First Company Valued at $4 Trillion
Declining Beer Consumption Signals Cultural Shift in Germany
Linda Yaccarino Steps Down as CEO of X After Two Years
×